ZA200202577B - Modified peptides and peptidomimetics for use in immonotherapy. - Google Patents

Modified peptides and peptidomimetics for use in immonotherapy. Download PDF

Info

Publication number
ZA200202577B
ZA200202577B ZA200202577A ZA200202577A ZA200202577B ZA 200202577 B ZA200202577 B ZA 200202577B ZA 200202577 A ZA200202577 A ZA 200202577A ZA 200202577 A ZA200202577 A ZA 200202577A ZA 200202577 B ZA200202577 B ZA 200202577B
Authority
ZA
South Africa
Prior art keywords
ser
gly
thr
ala
phe
Prior art date
Application number
ZA200202577A
Other languages
English (en)
Inventor
Catherina Joanna Van Straveren
Philippus Johannes Marie G Van
Anna Maria Helena Boots
Cornelis Marius Timmers
Rnaldus Marcellus Alph Knegtel
Andreas Marthinus M Miltenburg
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA200202577B publication Critical patent/ZA200202577B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200202577A 1999-10-18 2002-04-02 Modified peptides and peptidomimetics for use in immonotherapy. ZA200202577B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203427 1999-10-18

Publications (1)

Publication Number Publication Date
ZA200202577B true ZA200202577B (en) 2003-09-23

Family

ID=8240756

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200202577A ZA200202577B (en) 1999-10-18 2002-04-02 Modified peptides and peptidomimetics for use in immonotherapy.

Country Status (23)

Country Link
EP (1) EP1226167A1 (cs)
JP (1) JP2003512388A (cs)
KR (1) KR20020047245A (cs)
CN (1) CN1379786A (cs)
AR (1) AR026068A1 (cs)
AU (1) AU780238B2 (cs)
BR (1) BR0014803A (cs)
CA (1) CA2386398A1 (cs)
CO (1) CO5271650A1 (cs)
CZ (1) CZ20021356A3 (cs)
HK (1) HK1046693A1 (cs)
HU (1) HUP0203504A3 (cs)
IL (1) IL148778A0 (cs)
MX (1) MXPA02003520A (cs)
NO (1) NO20021763L (cs)
NZ (1) NZ518256A (cs)
PE (1) PE20010692A1 (cs)
PL (1) PL354590A1 (cs)
RU (1) RU2002113107A (cs)
SK (1) SK6842002A3 (cs)
TR (1) TR200201036T2 (cs)
WO (1) WO2001029081A1 (cs)
ZA (1) ZA200202577B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951212A0 (en) * 2002-09-04 2002-09-19 Monash University A method of modulating cellular activity and molecules for use therein
AU2007235305A1 (en) * 2006-04-06 2007-10-18 Purdue Research Foundation Derivatization-enhanced analysis of amino acids and peptides
US20100278745A1 (en) * 2006-12-21 2010-11-04 Norbert Lange Compounds for fluorescence imaging
CA2740028A1 (en) 2008-01-23 2009-07-30 Herlev Hospital Ykl-40 as a general marker for non-specific disease
CA2737292A1 (en) 2008-09-15 2010-03-18 Herlev Hospital Ykl-40 as a marker for gastrointestinal cancers
WO2016073949A1 (en) 2014-11-07 2016-05-12 Kineta Three, Llp Modifications and uses of conotoxin peptides
EP3466963A1 (en) * 2017-10-05 2019-04-10 Suigeneris Farmacosmetics, S.L. Anticancer peptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
TW575583B (en) * 1996-04-24 2004-02-11 Akzo Nobel Nv Novel peptides suitable for use in antigen specific immunosuppressive therapy
JP2000512277A (ja) * 1996-06-07 2000-09-19 ゼネカ・リミテッド ペプチド誘導体
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them

Also Published As

Publication number Publication date
NZ518256A (en) 2004-01-30
CZ20021356A3 (cs) 2002-07-17
NO20021763D0 (no) 2002-04-15
RU2002113107A (ru) 2004-01-10
CN1379786A (zh) 2002-11-13
BR0014803A (pt) 2002-06-11
WO2001029081A1 (en) 2001-04-26
HUP0203504A3 (en) 2005-03-29
PE20010692A1 (es) 2001-07-06
MXPA02003520A (es) 2002-08-20
SK6842002A3 (en) 2002-09-10
AR026068A1 (es) 2002-12-26
TR200201036T2 (tr) 2002-08-21
NO20021763L (no) 2002-04-15
JP2003512388A (ja) 2003-04-02
EP1226167A1 (en) 2002-07-31
AU1139601A (en) 2001-04-30
KR20020047245A (ko) 2002-06-21
IL148778A0 (en) 2002-09-12
HUP0203504A2 (hu) 2003-04-28
HK1046693A1 (zh) 2003-01-24
CA2386398A1 (en) 2001-04-26
CO5271650A1 (es) 2003-04-30
AU780238B2 (en) 2005-03-10
PL354590A1 (en) 2004-01-26

Similar Documents

Publication Publication Date Title
US6509033B1 (en) Immunomodulatory peptides
US20060093615A1 (en) Tumor antigen based on products of the tumor suppressor gent WT1
CA2415938A1 (en) Alpha-msh related compounds and methods of use
AU703120B2 (en) Composition and methods for enhancing immune responses mediated by antigen-presenting cells
WO1996012737A9 (en) Compositions and treatment for multiple sclerosis
EP0787147A1 (en) Compositions and treatment for multiple sclerosis
JP3468528B2 (ja) ペプチド誘導体
JPH09507861A (ja) 自己免疫疾患の免疫療法に用いるための、自己抗原から誘導された新規なペプチド
US7122193B1 (en) Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosis
AU780238B2 (en) Modified peptides and peptidomimetics for use in immunotherapy
AU718436B2 (en) Synthetic peptides and pharmaceutical compositions comprising them
JP2001504836A (ja) ペプチド誘導体
US6423315B1 (en) Synthetic peptide for treatment of autoimmune arthritis
AU758310B2 (en) Novel peptides for use in immunotherapy of autoimmune diseases
JP2001511143A (ja) コラーゲン▲ii▼に特異的なt細胞エピトープを含むペプチド
Boyer et al. Contribution of antigen processing to the recognition of a synthetic peptide antigen by specific T cell hybridomas
Skarlas et al. HLA‐DQ7 β1 and β2 derived peptides as immunomodulators
MXPA02009698A (es) Identificacion de peptidos de subunidad alfa del receptor de acetilcolina, inmunodominantes, potenciales.
Paz Antigenic peptides presented by MHC-I undergo intermediate processing steps in the cytosol and the endoplasmic reticulum